Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Combined Antibiotic Therapy for CRKP
NCT03950544Phase 1Unknown
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2019
- Primary completion
- Aug 2020
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of fosfomycin, tigecycline and polymyxin B in Klebsiella pneumoniae infection (4 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Fractional Inhibitory Concentration Index. Status: unknown.
02
Drugs
fosfomycintigecyclinepolymyxin B
03
Conditions
Klebsiella pneumoniae infection
Beyond the preview
Go deeper on NCT03950544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03950544.